Literature DB >> 11341850

New directions in the genetic mechanisms underlying nicotine addiction.

Marcus Munafò1, Elaine Johnstone, Michael Murphy, Robert Walton.   

Abstract

Major advances have been made in understanding nicotine addiction and smoking behaviour in recent years. In particular, evidence for the relative importance of genetic and environmental effects on smoking initiation and persistence has emerged from behaviour genetic studies. These data have supported evidence from molecular genetic studies for the role of particular candidate genes in tobacco dependence. Studies of the personality correlates of smoking behaviour suggest that these factors mediate the association between genetics and smoking initiation, while learning models of nicotine addiction suggest a role for dopaminergic genes in facilitating neuroadaptations associated with smoking persistence and development of nicotine dependence. Integrating these different avenues of research represents one of the most interesting and potentially fruitful ventures in the treatment of tobacco dependence.

Entities:  

Year:  2001        PMID: 11341850     DOI: 10.1080/13556210020040181

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  13 in total

1.  The genetics of tobacco use: methods, findings and policy implications.

Authors:  W Hall; P Madden; M Lynskey
Journal:  Tob Control       Date:  2002-06       Impact factor: 7.552

2.  A research agenda for assessing the potential contribution of genomic medicine to tobacco control.

Authors:  Wayne D Hall
Journal:  Tob Control       Date:  2007-02       Impact factor: 7.552

Review 3.  Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data.

Authors:  Marcus R Munafò; Nicholas J Timpson; Sean P David; Shah Ebrahim; Debbie A Lawlor
Journal:  Nicotine Tob Res       Date:  2009-01-27       Impact factor: 4.244

4.  Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary study.

Authors:  Pushplata Prasad; Atul Ambekar; Meera Vaswani
Journal:  BMC Med Genet       Date:  2010-02-11       Impact factor: 2.103

5.  Black and White adults' perspectives on the genetics of nicotine addiction susceptibility.

Authors:  Elyse R Park; Susan Kleimann; Emily J Youatt; Abigail Lockhart; Eric G Campbell; Douglas E Levy; Chanita Hughes Halbert; Erin Schmieder; Rasika Krishna; Alexandra E Shields
Journal:  Addict Behav       Date:  2011-02-25       Impact factor: 3.913

6.  Waterpipe Smoking And The DRD2/ANKK1 Genotype.

Authors:  Ghada N Radwan; Christopher A Loffredo; Maged A El Setouhy; Mohamed Abdel Hamid; Ebenezer J Israel; Mostafa K Mohamed
Journal:  J Egypt Public Health Assoc       Date:  2010

7.  Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation.

Authors:  Sean P David; Richard A Brown; George D Papandonatos; Christopher W Kahler; Elizabeth E Lloyd-Richardson; Marcus R Munafò; Peter G Shields; Caryn Lerman; David Strong; Jeanne McCaffery; Raymond Niaura
Journal:  Nicotine Tob Res       Date:  2007-08       Impact factor: 4.244

8.  Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes.

Authors:  Timothy B Baker; Robert B Weiss; Daniel Bolt; Andrew von Niederhausern; Michael C Fiore; Diane M Dunn; Megan E Piper; Nori Matsunami; Stevens S Smith; Hilary Coon; William M McMahon; Mary B Scholand; Nanda Singh; John R Hoidal; Su-Young Kim; Mark F Leppert; Dale S Cannon
Journal:  Nicotine Tob Res       Date:  2009-05-12       Impact factor: 4.244

9.  Will nicotine genetics and a nicotine vaccine prevent cigarette smoking and smoking-related diseases?

Authors:  Wayne D Hall
Journal:  PLoS Med       Date:  2005-09-27       Impact factor: 11.069

10.  Association of ankyrin repeats & kinase domain containing 1 (ANKK1) gene polymorphism with co-morbid alcohol & nicotine dependence: A pilot study from a tertiary care treatment centre in north India.

Authors:  Rizwana Quraishi; Raka Jain; Ashwani K Mishra; Atul Ambekar
Journal:  Indian J Med Res       Date:  2017-01       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.